Drug
Gsk-256066 clinical trials
Also written GSK256066.
- studies test it
- 10
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
10 studies that test it; most in 2007 (5)
| Year | Studies |
|---|---|
| 2006 | 3 |
| 2007 | 5 |
| 2008 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses gsk-256066 is read from its arms, and is right about nine times in ten.
Testing it · 10
- A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With RhinitisCompletedPhase 2GlaxoSmithKlineNCT00464568Written as GSK256066
- Endotoxin Challenge Study For Healthy Men and WomenCompletedPhase 1GlaxoSmithKlineNCT00515268Written as GSK256066
- Study To Evaluate Safety And Tolerability Of GSK256066 In Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedPhase 2GlaxoSmithKlineNCT00549679Written as GSK256066
- Clinical Endpoint Trial Investigating Once Daily and Bronchodilator DosingCompletedPhase 2GlaxoSmithKlineNCT00549744Written as GSK256066
- A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)CompletedPhase 2GlaxoSmithKlineNCT00612820Written as GSK256066
- Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge ChamberCompletedPhase 2GlaxoSmithKlineNCT00377728Written as GSK256066
- A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic RhinitisCompletedPhase 2GlaxoSmithKlineNCT00612118Written as GSK256066
- Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge ChamberCompletedPhase 2GlaxoSmithKlineNCT00430157Written as GSK256066
- This Study Will Examine the Effects of GSK256066 to Protect Mild Steroid-naive Asthmatics Against an Antigen ChallengeCompletedPhase 2GlaxoSmithKlineNCT00445510Written as GSK256066
- Study To Evaluate GSK256066 In Subjects With Mild Bronchial AsthmaCompletedPhase 2GlaxoSmithKlineNCT00380354Written as GSK256066
Codes
What other systems call gsk-256066 · ClinicalTrials.gg INT005627
- Wikidata Q27254589gsk-256066One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27254589 | gsk-256066 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.